$LTES
Leet Technology Inc Stock $ltes

$ltes Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000168316824002370 Filed on April 15, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$138.0K	$317.4K
YoY Change	283.41%	108.86%
Cost Of Revenue	$186.1K	$643.3K
YoY Change	-45.33%	-30.62%
Gross Profit	-$48.12K	-$325.9K
YoY Change	-84.19%	-57.96%
Gross Profit Margin	-34.87%	-102.67%
Selling, General & Admin	$346.0K	$1.193M
YoY Change	-10.1%	-29.47%
% of Gross Profit
Research & Development	-$53.26K	-$26.37K
YoY Change	-682.08%	-172.67%
% of Gross Profit
Depreciation & Amortization	$28.24K	$36.76K
YoY Change	-121.79%	15.89%
% of Gross Profit
Operating Expenses	$292.7K	$1.167M
YoY Change	-25.7%	-32.48%
Operating Profit	-$340.8K	-$1.493M
YoY Change	-51.2%	-40.37%
Interest Expense	$47.83K	$5.546K
YoY Change	-83.91%	112.57%
% of Operating Profit
Other Income/Expense, Net	$38.58K	$109.3K
YoY Change	56.7%	-172.97%
Pretax Income	-$254.4K	-$1.383M
YoY Change	-34.21%	-47.85%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$253.7K	-$1.379M
YoY Change	-33.74%	-47.96%
Net Earnings / Revenue	-183.87%	-434.31%
Basic Earnings Per Share		-$0.01
Diluted Earnings Per Share	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	151.1M shares	150.9M shares
Diluted Shares Outstanding		150.9M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.58K	$16.58K
YoY Change	-54.96%	-54.96%
Cash & Equivalents	$16.58K
Short-Term Investments
Other Short-Term Assets	$15.04K	$15.04K
YoY Change	28.44%	28.44%
Inventory
Prepaid Expenses
Receivables	$16.78K	$16.78K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$48.40K	$48.40K
YoY Change	-76.4%	-76.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.93K	$83.93K
YoY Change	-32.02%	-36.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$83.93K	$83.93K
YoY Change	-36.66%	-36.66%
TOTAL ASSETS
Total Short-Term Assets	$48.40K	$48.40K
Total Long-Term Assets	$83.93K	$83.93K
Total Assets	$132.3K	$132.3K
YoY Change	-60.8%	-60.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$60.38K	$796.6K
YoY Change	-88.61%	-12.47%
Accrued Expenses	$736.2K	$316.5K
YoY Change	93.81%	-25.09%
Deferred Revenue	$313.6K
YoY Change	15.81%
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.056M	$4.056M
YoY Change	41.81%	41.82%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.056M	$4.056M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$4.056M	$4.048M
YoY Change	41.81%	41.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.33M
YoY Change	16.6%
Common Stock	$15.11K
YoY Change	-1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.578M	-$3.916M
YoY Change
Total Liabilities & Shareholders Equity	$132.3K	$132.3K
YoY Change	-60.8%	-60.8%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$253.7K	-$1.379M
YoY Change	-33.74%	-47.96%
Depreciation, Depletion And Amortization	$28.24K	$36.76K
YoY Change	-121.79%	15.89%
Cash From Operating Activities	-$286.0K	-$1.316M
YoY Change	-55.22%	-29.74%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00	$1.953K
YoY Change	-84.62%	-79.17%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$20.00	-$1.953K
YoY Change	-99.99%	-83.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	343.7K	$1.401M
YoY Change	-39.42%	-25.99%
NET CHANGE
Cash From Operating Activities	-286.0K	-$1.316M
Cash From Investing Activities	20.00	-$1.953K
Cash From Financing Activities	343.7K	$1.401M
Net Change In Cash	57.70K	-$20.23K
YoY Change	-64.67%	-248.56%
FREE CASH FLOW
Cash From Operating Activities	-$286.0K	-$1.316M
Capital Expenditures	-$20.00	$1.953K
Free Cash Flow	-$286.0K	-$1.318M
YoY Change	-55.21%	-29.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001586495
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55053
CY2023	dei	Entity Registrant Name EntityRegistrantName	Leet Technology Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3590850
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	805, 8th Floor
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Menara Mutiara Majestic
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Jalan Othman, Petaling Jaya 46000
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Selangor
CY2023	dei	Entity Address Country EntityAddressCountry	MY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90035
CY2023	dei	City Area Code CityAreaCode	603
CY2023	dei	Local Phone Number LocalPhoneNumber	7783 1636
CY2023	dei	Security12g Title Security12gTitle	Common Stock, par value $0.0001
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	151096262	shares
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2260949	usd
CY2023	dei	Auditor Firm AuditorFirmId	6723
CY2022	dei	Auditor Firm AuditorFirmId	2485
CY2023	dei	Auditor Name AuditorName	JP CENTURION & PARTNERS PLT
CY2023	dei	Auditor Location AuditorLocation	Kuala Lumpur, Malaysia
CY2023	dei	Auditor Firm AuditorFirmId	6723
CY2022	dei	Auditor Name AuditorName	Simon & Edward, LLP
CY2022	dei	Auditor Location AuditorLocation	Rowland Heights, CA
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16580	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36808	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16781	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	156585	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	15036	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	11712	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	48397	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	205105	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83932	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	123458	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9046	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	83932	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	132504	usd
CY2023Q4	us-gaap	Assets Assets	132329	usd
CY2022Q4	us-gaap	Assets Assets	337609	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	60378	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	530198	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736212	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	379872	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	316471	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	413443	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	313616	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	270795	usd
CY2023Q4	LTES	Due To Related Party Current DueToRelatedPartyCurrent	2629435	usd
CY2022Q4	LTES	Due To Related Party Current DueToRelatedPartyCurrent	1157166	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	99624	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9046	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4056112	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2860144	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4056112	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2860144	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5662325	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5284837	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	151096262	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	151096262	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152899640	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152899640	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	15110	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	15290	usd
CY2023Q4	LTES	Common Stock To Be Cancelled CommonStockToBeCancelled	-0	usd
CY2022Q4	LTES	Common Stock To Be Cancelled CommonStockToBeCancelled	100	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2773081	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2773001	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32074	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14021	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12334229	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10578195	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-9578012	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7803925	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-8096	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-3447	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9586108	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7807372	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132329	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	337609	usd
CY2023	us-gaap	Revenues Revenues	317413	usd
CY2022	us-gaap	Revenues Revenues	151977	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	643316	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	927194	usd
CY2023	us-gaap	Gross Profit GrossProfit	-325903	usd
CY2022	us-gaap	Gross Profit GrossProfit	-775217	usd
CY2023	LTES	Research And Development Expense Reversal ResearchAndDevelopmentExpenseReversal	26373	usd
CY2022	LTES	Research And Development Expense Reversal ResearchAndDevelopmentExpenseReversal	-36287	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1193173	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1691688	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1166800	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1727975	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1492703	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2503192	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1575	usd
CY2023	LTES	Common Stock Cancellation CommonStockCancellation	0	usd
CY2022	LTES	Common Stock Cancellation CommonStockCancellation	300000	usd
CY2023	LTES	Cybersecurity Service Income CybersecurityServiceIncome	66930	usd
CY2022	LTES	Cybersecurity Service Income CybersecurityServiceIncome	18609	usd
CY2023	LTES	Foreign Exchange Gain Currency Transaction Gain Loss Before Tax ForeignExchangeGainCurrencyTransactionGainLossBeforeTax	64948	usd
CY2022	LTES	Foreign Exchange Gain Currency Transaction Gain Loss Before Tax ForeignExchangeGainCurrencyTransactionGainLossBeforeTax	0	usd
CY2023	LTES	Loss On Settlement With Related Parties LossOnSettlementWithRelatedParties	-0	usd
CY2022	LTES	Loss On Settlement With Related Parties LossOnSettlementWithRelatedParties	471860	usd
CY2023	LTES	Impairment Of Other Receivable ImpairmentOfOtherReceivable	1301	usd
CY2022	LTES	Impairment Of Other Receivable ImpairmentOfOtherReceivable	-0	usd
CY2023	us-gaap	Interest Expense InterestExpense	5546	usd
CY2022	us-gaap	Interest Expense InterestExpense	2609	usd
CY2023	LTES	Recovery Written Off Of Accounts Receivable RecoveryWrittenOffOfAccountsReceivable	-32035	usd
CY2022	LTES	Recovery Written Off Of Accounts Receivable RecoveryWrittenOffOfAccountsReceivable	0	usd
CY2023	LTES	Sundry Income Expense Net SundryIncomeExpenseNet	44600	usd
CY2022	LTES	Sundry Income Expense Net SundryIncomeExpenseNet	4548	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	109256	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-149737	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1383447	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2652929	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4901	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1378546	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2649117	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4649	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3812	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1396599	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2650608	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1401248	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2654420	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150877491	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	150877491	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152899640	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152899640	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4769184	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2754012	usd
CY2022	LTES	Acquisition Of Leet Bd AcquisitionOfLeetBd	365	usd
CY2022	LTES	Disposal Of Subsidiaries DisposalOfSubsidiaries	10239	usd
CY2022	us-gaap	Dividends Dividends	94372	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	300000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1491	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2652929	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7807372	usd
CY2023	us-gaap	Dividends Dividends	377488	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-17801	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1383447	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9586108	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1383447	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2652929	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36755	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31721	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4817	usd
CY2023	LTES	Impairment Loss On Other Receivables ImpairmentLossOnOtherReceivables	1301	usd
CY2022	LTES	Impairment Loss On Other Receivables ImpairmentLossOnOtherReceivables	0	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	32035	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-0	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1575	usd
CY2023	LTES	Noncash Financing Cost NoncashFinancingCost	5546	usd
CY2022	LTES	Noncash Financing Cost NoncashFinancingCost	2609	usd
CY2023	LTES	Common Stock Cancellations CommonStockCancellations	-0	usd
CY2022	LTES	Common Stock Cancellations CommonStockCancellations	300000	usd
CY2023	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	28340	usd
CY2022	LTES	Loss On Early Redemption Of Convertible Promissory Note LossOnEarlyRedemptionOfConvertiblePromissoryNote	0	usd
CY2023	LTES	Loss On Settlement With Related Party LossOnSettlementWithRelatedParty	0	usd
CY2022	LTES	Loss On Settlement With Related Party LossOnSettlementWithRelatedParty	471860	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-28178	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	113061	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	3826	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-12027	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-451784	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9139	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	347189	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	329020	usd
CY2023	LTES	Accrued Compensation Payable To Officers And Directors AccruedCompensationPayableToOfficersAndDirectors	-10613	usd
CY2022	LTES	Accrued Compensation Payable To Officers And Directors AccruedCompensationPayableToOfficersAndDirectors	66810	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	54177	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	271187	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4779	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1316149	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9046	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1873154	usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	8448	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9046	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	usd
CY2023	LTES	Disposal Of Cash From Subsidiaries DisposalOfCashFromSubsidiaries	-0	usd
CY2022	LTES	Disposal Of Cash From Subsidiaries DisposalOfCashFromSubsidiaries	11012	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1953	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9376	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1953	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11940	usd
CY2023	LTES	Proceeds From Repayments Of Director ProceedsFromRepaymentsOfDirector	95611	usd
CY2022	LTES	Proceeds From Repayments Of Director ProceedsFromRepaymentsOfDirector	-1464	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	100000	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	113300	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1418603	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1794334	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1400914	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1892870	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-103039	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5840	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20228	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13616	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36808	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23192	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16580	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36808	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	LTES	Issuance Of Series B Convertible Preferred Stock In Exchange Of Balances Due To Related Parties IssuanceOfSeriesBConvertiblePreferredStockInExchangeOfBalancesDueToRelatedParties	0	usd
CY2022	LTES	Issuance Of Series B Convertible Preferred Stock In Exchange Of Balances Due To Related Parties IssuanceOfSeriesBConvertiblePreferredStockInExchangeOfBalancesDueToRelatedParties	4718605	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	12408	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	7000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	151096262	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	151096262	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16580	usd
CY2023Q4	LTES	Working Capital WorkingCapital	-4007715	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12334229	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1383447	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_ztHZ86Yv3dck" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_865_zBTXvCfaqfrl">Use of estimates and assumptions</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements during the years reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2023	us-gaap	Revenues Revenues	317413	usd
CY2022	us-gaap	Revenues Revenues	151977	usd
CY2022	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	20000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	164311	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	169210	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80379	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45752	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83932	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	123458	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36755	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31721	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9046	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	152899640	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	152899640	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-1383447	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2652929	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150877491	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	150877491	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	152899640	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	152899640	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1383447	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2652929	usd
CY2023Q4	LTES	Due To Related Party Current And Noncurrent DueToRelatedPartyCurrentAndNoncurrent	2629435	usd
CY2022Q4	LTES	Due To Related Party Current And Noncurrent DueToRelatedPartyCurrentAndNoncurrent	1157166	usd
CY2023	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	53619	usd
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	148631	usd
CY2023Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	3152	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-002370-index-headers.html	Edgar Link	pending
0001683168-24-002370-index.html	Edgar Link	pending
0001683168-24-002370.txt	Edgar Link	pending
0001683168-24-002370-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
leet_ex3101.htm	Edgar Link	pending
leet_ex3102.htm	Edgar Link	pending
leet_ex3201.htm	Edgar Link	pending
leet_ex3202.htm	Edgar Link	pending
leet_i10k-123123.htm	Edgar Link	pending
ltes-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
ltes-20231231_cal.xml	Edgar Link	unprocessable
ltes-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ltes-20231231_lab.xml	Edgar Link	unprocessable
ltes-20231231_pre.xml	Edgar Link	unprocessable
leet_i10k-123123_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LTES
Leet Technology Inc Stock $ltes

2023 Q4 Form 10-K Financial Statement

#000168316824002370 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTES Leet Technology Inc Stock $ltes

2023 Q4 Form 10-K Financial Statement

#000168316824002370 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LTES
Leet Technology Inc Stock $ltes